Similar Articles
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Issue: 1998, Volume 4 - Issue 1-2
0
261
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
Issue: 1995, Volume 1 - Issue 3
0
233
Anxiety and Depression in Chronic Headache
Deniz SELÇUKİ, Canan YÜCESAN, Nermin MUTLUER, Rana TANRIDAĞ, Gönül OZAN
Issue: 1995, Volume 1 - Issue 3
0
299
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Issue: 1995, Volume 1 - Issue 1
0
282
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Issue: 1995, Volume 1 - Issue 1
0
258
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Issue: 2009, Volume 15 - Supplement 3
0
321
The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study
Emir Ruşen, Gaye Hafez, Yeşim Tunç
DOI: 10.55697/tnd.2024.18
Issue: 2024, Volume 30 - Issue 1
1715
803
Could pulsed radiofrequency stimulation of the proximal greater occipital nerve be a treatment option for refractory chronic migraine patients?
Derya Yavuz Demiray, Ferhat Ege
DOI: 10.55697/tnd.2024.1
Issue: 2024, Volume 30 - Issue 4
719
493
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216
Issue: 2025, Volume 31 - Issue 1
265
184
The comparative clinical effectiveness of withdrawal treatment with greater occipital nerve block at the C2 level with dexamethasone or bupivacaine in medication-overuse headache
Mustafa Karaoglan, Anıl Kılınç
DOI: 10.55697/tnd.2025.299
Issue: Online First
0
32